amphotericin b

amphotericin b is a lipid of Polyketides (PK) class. Amphotericin b often locates in Mitochondria.

Cross Reference

Introduction

To understand associated biological information of amphotericin b, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with amphotericin b

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with amphotericin b?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What lipids are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What genes are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with amphotericin b?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with amphotericin b

Download all related citations
Per page 10 20 50 100 | Total 10373
Authors Title Published Journal PubMed Link
Song Z et al. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B. 2019 Carbohydr Polym pmid:30446143
Yamamoto T et al. Claviform aspergillus-related vegetation in the left ventricle of a patient with systemic lupus erythematosus. 2018 J Clin Ultrasound pmid:28568285
Rotjanapan P et al. Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries. 2018 Med. Mycol. pmid:28525619
Foster CE et al. Trichosporonosis in Pediatric Patients With a Hematologic Disorder. 2018 J Pediatric Infect Dis Soc pmid:28510690
Uppar A et al. Intracranial Cryptococcoma-Clinicopathologic Correlation and Surgical Outcome: A Single-Institution Experience. 2018 World Neurosurg pmid:29678697
Duncan K et al. Efficacy of Amphotericin B Against Fusarium and Aspergillus in Corneal Storage Medium. 2018 Eye Contact Lens pmid:30376531
Vásquez Marcano RGDJ et al. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery. 2018 Carbohydr Polym pmid:30287009
Adamczick C et al. Double trouble: visceral leishmaniasis in twins after traveling to Tuscany - a case report. 2018 BMC Infect. Dis. pmid:30285634
Monroig-Bosque PDC et al. The utility of therapeutic plasma exchange for amphotericin B overdose. 2018 Transfus. Apher. Sci. pmid:30274949
Krishnan RA et al. Protective nature of low molecular weight chitosan in a chitosan-Amphotericin B nanocomplex - A physicochemical study. 2018 Mater Sci Eng C Mater Biol Appl pmid:30274080
Wheat J et al. Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. 2018 Medicine (Baltimore) pmid:29595679
Molloy SF et al. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. 2018 N. Engl. J. Med. pmid:29539274
Oyama J et al. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case. 2018 Rev. Inst. Med. Trop. Sao Paulo pmid:29451600
Mendonça DVC et al. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. 2018 Exp. Parasitol. pmid:29448040
Casa DM et al. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. 2018 Exp. Parasitol. pmid:30026113
Ling Q et al. Disseminated histoplasmosis in an immunocompetent patient from an endemic area: A case report. 2018 Medicine (Baltimore) pmid:30024525
Swan CD and Gottlieb T empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature. 2018 BMJ Case Rep pmid:30021735
Khedri S et al. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species. 2018 Lett. Appl. Microbiol. pmid:30019443
Xu S et al. Biguanides enhance antifungal activity against Candida glabrata. 2018 Virulence pmid:29962263
Coêlho ES et al. Emulgel based on amphotericin B and bacuri butter (Platonia insignis Mart.) for the treatment of cutaneous leishmaniasis: characterization and in vitro assays. 2018 Drug Dev Ind Pharm pmid:29961344
Werge M et al. Evaluation of local instillation of antibiotics in infected walled-off pancreatic necrosis. 2018 Pancreatology pmid:29958817
Shahani L Disseminated histoplasmosis mimicking relapsed chronic lymphocytic leukaemia. 2018 BMJ Case Rep pmid:29954761
Shrestha M et al. Visceral leishmaniasis from a non-endemic Himalayan region of Nepal. 2018 Parasitol. Res. pmid:29717371
Nicolas G et al. Leishmania in a Patient with Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia. 2018 Am J Case Rep pmid:29712885
Franco-Muñoz C et al. Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia. 2018 PLoS ONE pmid:29698432
Zhang J et al. Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation. 2018 BMC Cancer pmid:29695237
Usman F et al. Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. 2018 AAPS PharmSciTech pmid:29691753
Hoarau G et al. [Fungal keratitis: A 5-year monocentric retrospective study on Reunion Island]. 2018 J Fr Ophtalmol pmid:29681463
Bozkurt-Guzel C et al. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species. 2018 Diagn. Microbiol. Infect. Dis. pmid:29680320
Ponzio V et al. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system. 2018 Transpl Infect Dis pmid:29677399
Nishioka H et al. Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. 2018 J. Infect. Chemother. pmid:29021093
Zhang B et al. Improvement of amphotericin B production by a newly isolated Streptomyces nodosus mutant. 2018 Biotechnol. Appl. Biochem. pmid:28762559
Posch W et al. Aspergillus terreus: Novel lessons learned on amphotericin B resistance. 2018 Med. Mycol. pmid:29538736
Lei HL et al. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. 2018 Eur. J. Clin. Microbiol. Infect. Dis. pmid:29536323
Jain S et al. Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement. 2018 AAPS PharmSciTech pmid:29532426
Kaneko Y et al. Successful Treatment of Intestinal Mycosis Caused by a Simultaneous Infection with Lichtheimia ramosa and Aspergillus calidoustus. 2018 Intern. Med. pmid:29526942
Efimova SS et al. Lipid-mediated mode of action of local anesthetics on lipid pores induced by polyenes, peptides and lipopeptides. 2018 Colloids Surf B Biointerfaces pmid:29525621
Öner T et al. Rare presentation of Candida albicans: infective endocarditis and a pulmonary coin lesion. 2018 Cardiol Young pmid:29513204
Challener D and Abu Saleh O Disseminated blastomycosis in a transplant patient. 2018 Transpl Infect Dis pmid:29512289
Nambiar P et al. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation. 2018 Transpl Infect Dis pmid:29512240
Kural C et al. Intracavitary amphotericin B in the treatment of intracranial aspergillosis. 2018 J Clin Neurosci pmid:29506772
Gurudevan S et al. Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity. 2018 Eur J Pharm Sci pmid:29325755
Mohamed HA et al. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study. 2018 Drug Deliv Transl Res pmid:29280061
Polley SD et al. Visceral Leishmaniasis in Traveler to Guyana Caused by Leishmania siamensis, London, UK. 2018 Emerging Infect. Dis. pmid:29260661
Yoshida M et al. Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications. 2018 Mycopathologia pmid:29249044
Chao J et al. Follicular papules and pustules in a patient with pulmonary symptoms. 2018 Clin. Exp. Dermatol. pmid:29226980
Watanabe A et al. Stability and drug release studies of an antimycotic nanomedicine using HPLC, dynamic light scattering and atomic force microscopy. 2018 J Pharm Biomed Anal pmid:29028561
He R et al. Report of 12 cases with tracheobronchial mucormycosis and a review. 2018 Clin Respir J pmid:29028140
Cavalcante CSP et al. Insights into the candidacidal mechanism of Ctn[15-34] - a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins. 2018 J. Med. Microbiol. pmid:29214974
Kassi FK et al. Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast. 2018 J. Med. Microbiol. pmid:29214970